propranolol has been researched along with olanzapine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 13 (56.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Handzlik, J; Jankowska, A; Jastrzębska-Więsek, M; Kieć-Kononowicz, K; Kucwaj-Brysz, K; Kurczab, R; Nitek, W; Partyka, A; Satała, G; Siwek, A; Wesołowska, A; Żesławska, E | 1 |
| Fleischhacker, WW; Hummer, M; Kohl, C; Kurzthaler, I; Miller, C | 1 |
| Fujiwara, Y; Hamamura, T; Kuroda, S; Lee, Y; Ohashi, K; Suzuki, H | 1 |
| Raskind, MA; Rosin, RA | 1 |
| Başoğlu, M; Irtman, G; Kurt, T; Yetimalar, Y | 1 |
| Bonnel, D; Bouzom, F; Delbos, JM; Hamm, G; Legouffe, R; Pamelard, F; Stauber, J | 1 |
| Ikeda, H; Ikegami, M; Ishikawa, Y; Kai, M; Kamei, A; Kamei, J; Ohashi, T; Ohsawa, M | 1 |
| Carbajal, R; Castillo, V; Maddock, S; Williamson, JE | 1 |
| Ishiwata, Y; Nagata, M; Nakajima, M; Negishi, K; Takahashi, H; Takahashi, Y; Yasuhara, M | 1 |
| Deng, S; Hu, J; Qiu, C; Shang, D; Wen, Y; Zhu, X | 1 |
1 review(s) available for propranolol and olanzapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for propranolol and olanzapine
| Article | Year |
|---|---|
Olanzapine versus propranolol in essential tremor.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Benzodiazepines; Cross-Over Studies; Double-Blind Method; Essential Tremor; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Propranolol; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2005 |
21 other study(ies) available for propranolol and olanzapine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT
Topics: Animals; Antidepressive Agents; Behavior, Animal; Computer-Aided Design; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Hydantoins; Male; Mice; Models, Molecular; Molecular Structure; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship | 2018 |
Propranolol treatment of olanzapine-induced akathisia.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Drug Administration Schedule; Female; Humans; Infant; Olanzapine; Pirenzepine; Propranolol; Schizophrenia, Paranoid | 1997 |
Clozapine- and olanzapine-induced Fos expression in the rat medial prefrontal cortex is mediated by beta-adrenoceptors.
Topics: Adrenergic beta-Antagonists; Animals; Antipsychotic Agents; Benzodiazepines; Cell Count; Cell Nucleus; Clozapine; Locus Coeruleus; Male; Neurons; Olanzapine; Pirenzepine; Prefrontal Cortex; Propranolol; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, Adrenergic, beta | 2000 |
Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: a case report.
Topics: Aged; Aggression; Alzheimer Disease; Amines; Antipsychotic Agents; Benzodiazepines; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Gabapentin; gamma-Aminobutyric Acid; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Olanzapine; Propranolol; Quetiapine Fumarate; Risperidone; Testosterone; Trazodone; Treatment Outcome; Valproic Acid | 2005 |
Psychopharmacology news. New side effects of agents.
Topics: Benzodiazepines; Bupropion; Female; Humans; Olanzapine; Pregnancy; Propranolol; Psychotropic Drugs; Valproic Acid | 2007 |
Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor.
Topics: Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Benzodiazepines; Diagnostic Imaging; Male; Mass Spectrometry; Mice; Models, Biological; Models, Theoretical; Olanzapine; Propranolol; Rats; Rats, Wistar; Reference Standards; Research Design; Tissue Distribution | 2012 |
Olanzapine increases hepatic glucose production through the activation of hypothalamic adenosine 5'-monophosphate-activated protein kinase.
Topics: Adrenergic beta-Antagonists; AMP-Activated Protein Kinases; Animals; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Enzymes; Homeostasis; Hypothalamus; Liver; Male; Mice; Olanzapine; Phosphorylation; Propranolol; Protein Kinase Inhibitors; Pyruvic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2013 |
Hyponatremia as a result of posttraumatic primary polydipsia.
Topics: Adrenergic beta-Antagonists; Antipsychotic Agents; Benzodiazepines; Craniocerebral Trauma; Humans; Hyponatremia; Male; Middle Aged; Olanzapine; Polydipsia, Psychogenic; Propranolol | 2015 |
Mechanism Underlying Induction of Hyperglycemia in Rats by Single Administration of Olanzapine.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Corticosterone; Epinephrine; Glucagon; Histamine; Hyperglycemia; Injections, Intravenous; Insulin; Male; Models, Biological; Olanzapine; Propranolol; Rats, Wistar | 2016 |
Sleepwalking Is Associated With Coadministration of Olanzapine and Propranolol: A Case Report.
Topics: Adrenergic beta-Antagonists; Akathisia, Drug-Induced; Antipsychotic Agents; Drug Therapy, Combination; Female; Humans; Middle Aged; Olanzapine; Propranolol; Schizophrenia; Somnambulism | 2017 |